Everence Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$211K	Hold	5,850	–	–	0.01%	736
2025 Q1	$231K	Buy	+5,850	New	+$231K	0.02%	690
2024 Q4	–	Sell	-16,260	Closed	-$380K	–	1025
2024 Q3	$380K	Buy	+16,260	New	+$380K	0.02%	508